These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9036965)

  • 41. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
    Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
    FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
    Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
    J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conformational dynamics of complementarity-determining region H3 of an anti-dansyl Fv fragment in the presence of its hapten.
    Nakasako M; Oka T; Mashumo M; Takahashi H; Shimada I; Yamaguchi Y; Kato K; Arata Y
    J Mol Biol; 2005 Aug; 351(3):627-40. PubMed ID: 16019026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystal structure of anti-Hen egg white lysozyme antibody (HyHEL-10) Fv-antigen complex. Local structural changes in the protein antigen and water-mediated interactions of Fv-antigen and light chain-heavy chain interfaces.
    Kondo H; Shiroishi M; Matsushima M; Tsumoto K; Kumagai I
    J Biol Chem; 1999 Sep; 274(39):27623-31. PubMed ID: 10488102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-dimensional structures of a humanized anti-IFN-gamma Fab (HuZAF) in two crystal forms.
    Bourne PC; Terzyan SS; Cloud G; Landolfi NF; Vásquez M; Edmundson AB
    Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1761-9. PubMed ID: 15388922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformational correction mechanisms aiding antigen recognition by a humanized antibody.
    Holmes MA; Buss TN; Foote J
    J Exp Med; 1998 Feb; 187(4):479-85. PubMed ID: 9463398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystallographic analysis of the NNA7 Fab and proposal for the mode of human blood-group recognition.
    Xie K; Song SC; Spitalnik SL; Wedekind JE
    Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1386-94. PubMed ID: 16204891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SDR grafting--a new approach to antibody humanization.
    Kashmiri SV; De Pascalis R; Gonzales NR; Schlom J
    Methods; 2005 May; 36(1):25-34. PubMed ID: 15848072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crystal structure of a shark single-domain antibody V region in complex with lysozyme.
    Stanfield RL; Dooley H; Flajnik MF; Wilson IA
    Science; 2004 Sep; 305(5691):1770-3. PubMed ID: 15319492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands.
    Padlan EA
    Proteins; 1990; 7(2):112-24. PubMed ID: 1691497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
    Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
    Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
    Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
    Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural patterns at residue positions 9, 18, 67 and 82 in the VH framework regions of human and murine immunoglobulins.
    Saul FA; Poljak RJ
    J Mol Biol; 1993 Mar; 230(1):15-20. PubMed ID: 8450531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary X-ray analysis of a human V(H) fragment at 1.8 A resolution.
    Gaur RK; Kupper MB; Fischer R; Hoffmann KM
    Acta Crystallogr D Biol Crystallogr; 2004 May; 60(Pt 5):965-7. PubMed ID: 15103154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
    Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
    Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.